Inicio・Lista de Acciones・Tandem Diabetes Care Inc

Tandem Diabetes Care Inc

Cerrado

SectorSanidad

22.7 -1.52

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

22.35

Máximo

22.78

Métricas clave
By Trading Economics
Ingresos	-775K -21M
Ventas	7.3M 255M
BPA	-0.31
Margen de beneficios	-8.316
Empleados	2,500
EBITDA	4.5M -9.2M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+16.64% upside

Dividendos
By Acuity
Próximas Ganancias	5 nov 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	209M 1.6B
Apertura anterior	24.22
Cierre anterior	22.7

Noticias sobre sentimiento de mercado

By Acuity

50%

142 / 340 Clasificación en Healthcare

Tandem Diabetes Care Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

14 ago 2026, 20:06 UTC

Tandem Diabetes Care shares are lower today amid economic concerns following a disappointing U.S. retail sales report for July. The stock remains above its 20-day moving average.

13 ago 2026, 19:16 UTC

Tandem Diabetes Care shares are trading lower today, despite broader market support and an early high. Initial jobless claims rose, indicating potential labor market softening.

12 ago 2026, 19:41 UTC

News

Tandem Diabetes Care reported a narrower second-quarter loss of 31 cents per share, with revenues of $254.6 million, as shares rise since Tuesday.

11 ago 2026, 19:46 UTC

News

Tandem Diabetes Care reported improved second-quarter results, including a narrower loss and increased revenue, supporting shares' advance during Tuesday's session.

10 ago 2026, 19:36 UTC

News

Tandem Diabetes Care reported second-quarter revenue of $254.6 million and reaffirmed its full-year guidance of $1.08 billion, supporting a higher share price today.

7 ago 2026, 20:02 UTC

News

Tandem Diabetes Care shares rose after Q2 sales of $254.6 million and adjusted EBITDA of $6.4 million exceeded forecasts, despite RBC lowering its price target to $26.

6 ago 2026, 23:02 UTC

News

Tandem Diabetes Care reported Q2 sales of $254.6 million and reaffirmed revenue guidance, with shares trading higher in after-market hours.

5 ago 2026, 19:56 UTC

News

Tandem Diabetes Care Inc's shares are declining amid negative sentiment in the insulin sector following Insulet Corp's lowered revenue growth forecast.

4 ago 2026, 19:46 UTC

Tandem Diabetes Care Inc shares are lower today, influenced by declines in the Health Care Equipment sub-sector. Earlier, the stock reached a session high before pulling back.

31 jul 2026, 19:51 UTC

Tandem Diabetes Care Inc is advancing today, benefiting from positive market sentiment driven by technology stocks, despite pulling back from earlier session highs.

30 jul 2026, 17:11 UTC

Tandem Diabetes Care shares are lower today as the Health Care Equipment sub-sector declines. The asset remains above its 20-day moving average.

29 jul 2026, 18:15 UTC

Tandem Diabetes Care Inc. shares are higher, driven by significant gains in Health Care Equipment stocks, despite a recent trend of daily price increases.

27 jul 2026, 19:21 UTC

Tandem Diabetes Care Inc. shares are lower, reflecting broader market trends amid declining oil prices and easing geopolitical tensions ahead of the Federal Reserve meeting.

24 jul 2026, 14:02 UTC

Tandem Diabetes Care Inc shares are lower today, with no specific news identified. Broader market concerns follow a significant sell-off on Thursday.

21 jul 2026, 19:06 UTC

Tandem Diabetes Care is lower today, driven by declines in the Health Care Equipment sub-sector. The asset has fallen steadily after an early high.

20 jul 2026, 17:26 UTC

Tandem Diabetes Care Inc shares are higher today, recovering from an early dip. The stock has gained significantly since last month’s close.

Comparación entre iguales

Cambio de precio

Tandem Diabetes Care Inc previsión

Precio Objetivo

By TipRanks

16.64% repunte

Estimación a 12 Meses

Media 26.5 USD 16.64%

Máximo 50 USD

Mínimo 15.5 USD

De acuerdo con 15 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Tandem Diabetes Care Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

15 ratings

Comprar

Mantener

Vender

De acuerdo con 15 analistas que ofrecen calificaciones bursátiles a para Tandem Diabetes Care Inc Dist en los últimos 3 meses.

Sentimiento

By Acuity

142 / 340 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Tandem Diabetes Care Inc

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.